help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on January 24, 2008
Molecular Endocrinology, doi:10.1210/me.2007-0407
Molecular Endocrinology Vol. 0, No. 2008 200704071-
doi:10.1210/me.2007-0407
Copyright © 2008 by the Endocrine Society.
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
22/5/1171    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mizutori, Y.
Right arrow Articles by Rapoport, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mizutori, Y.
Right arrow Articles by Rapoport, B.

Submitted on August 27, 2007
Accepted on January 18, 2008

The Thyrotropin Receptor Hinge Region Is Not Simply a Scaffold for the Leucine-Rich Domain but Contributes to Ligand Binding and Signal Transduction

Yumiko Mizutori, Chun-Rong Chen, Sandra M. McLachlan, and Basil Rapoport*

Autoimmune Disease Unit, Cedars-Sinai Research Institute and UCLA School of Medicine, Los Angeles, California

* To whom correspondence should be addressed. E-mail: rapoportb{at}cshs.org.

The glycoprotein hormone receptor hinge region connects the leucine-rich and transmembrane domains. The prevalent concept is that the hinge does not play a significant role in ligand binding and signal transduction. Portions of the hinge are redundant and can be deleted by mutagenesis or are absent in certain species. A ‘minimal’ hinge will be more amenable to future investigation of its structure and function. We, therefore, combined and progressively extended previous deletions ({Delta}) in the TSH receptor (TSHR) hinge region (residues 277-418). TSHR{Delta}287-366, {Delta}287-371, {Delta}287-376, and {Delta}287-384 progressively lost their response to TSH stimulation of cAMP generation in intact cells, consistent with a progressive loss of TSH binding. The longest deletion (TSHR{Delta}287-384), reducing the hinge region from 141 to 43 amino acids, totally lost both functions. Surprisingly, however, with deletions extending from residues 371-384 constitutive (ligand-independent) activity increased several fold, reversing the suppressive (inverse agonist) effect of the TSHR extracellular domain. TSHR activating point mutations I486F and I568T in the first and second extracellular loops (especially the former) had reduced activity on a background of TSHR{Delta}287-371.

In summary, our data support the concept that the TSHR hinge contributes significantly to ligand binding affinity and signal transduction. Residues within the hinge, particularly between positions 371 and 384, appear involved in ectodomain inverse agonist activity. In addition, the hinge is necessary for functionality of activating mutations in the first and second extracellular loops. Rather than being an inert linker between the leucine-rich and transmembrane domains, the TSHR hinge is a ‘signaling-specificity’ domain.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Bruysters, M. Verhoef-Post, and A. P. N. Themmen
Asp330 and Tyr331 in the C-terminal Cysteine-rich Region of the Luteinizing Hormone Receptor Are Key Residues in Hormone-induced Receptor Activation
J. Biol. Chem., September 19, 2008; 283(38): 25821 - 25828.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
R Nunez Miguel, J Sanders, D Y Chirgadze, T L Blundell, J Furmaniak, and B Rees Smith
FSH and TSH binding to their respective receptors: similarities, differences and implication for glycoprotein hormone specificity
J. Mol. Endocrinol., September 1, 2008; 41(3): 145 - 164.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C.-R. Chen, S. M. McLachlan, and B. Rapoport
Identification of Key Amino Acid Residues in a Thyrotropin Receptor Monoclonal Antibody Epitope Provides Insight into Its Inverse Agonist and Antagonist Properties
Endocrinology, July 1, 2008; 149(7): 3427 - 3434.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society